|
|
|
|
|
|
|
| | |
bladder urothelial carcinoma
|
KDM6A*
|
Kdm6a
|
|
Alliance of Genome Resources
|
transitional cell carcinoma
|
BCL2*
|
Bcl2
|
|
Alliance of Genome Resources
|
transitional cell carcinoma
|
BCL2L1*
|
Bcl2l1
|
|
Alliance of Genome Resources
|
transitional cell carcinoma
|
BIRC5*
|
Birc5
|
|
Alliance of Genome Resources
|
transitional cell carcinoma
|
CCND2*
|
Ccnd2
|
|
Alliance of Genome Resources
|
transitional cell carcinoma
|
CD44*
|
Cd44
|
|
Alliance of Genome Resources
|
transitional cell carcinoma
|
CDKN2A*
|
Cdkn2a
|
|
Alliance of Genome Resources
|
transitional cell carcinoma
|
CDKN2B*
|
Cdkn2b
|
|
Alliance of Genome Resources
|
transitional cell carcinoma
|
FGFR3*
|
Fgfr3
|
|
Alliance of Genome Resources
|
transitional cell carcinoma
|
GSTM1*,
GSTM5
|
Gstm1,
Gstm2,
Gstm3,
Gstm6
|
|
Alliance of Genome Resources
|
transitional cell carcinoma
|
HRAS*
|
Hras
|
|
Alliance of Genome Resources
|
transitional cell carcinoma
|
APC*
|
Apc
|
|
Alliance of Genome Resources
|
transitional cell carcinoma
|
MSH2*
|
Msh2
|
|
Alliance of Genome Resources
|
transitional cell carcinoma
|
MTHFR*
|
Mthfr
|
|
Alliance of Genome Resources
|
transitional cell carcinoma
|
NAT2*,
NAT1
|
Nat1,
Nat2,
Nat3
|
|
Alliance of Genome Resources
|
transitional cell carcinoma
|
OGG1*
|
Ogg1
|
|
Alliance of Genome Resources
|
transitional cell carcinoma
|
RAD50*
|
Rad50
|
|
Alliance of Genome Resources
|
transitional cell carcinoma
|
RASSF1*
|
Rassf1
|
|
Alliance of Genome Resources
|
transitional cell carcinoma
|
SFN*
|
Sfn
|
|
Alliance of Genome Resources
|
transitional cell carcinoma
|
TP63*
|
Trp63
|
|
Alliance of Genome Resources
|
transitional cell carcinoma
|
TYMP*
|
Tymp
|
|
Alliance of Genome Resources
|
transitional cell carcinoma
|
XRCC1*
|
Xrcc1
|
|
Alliance of Genome Resources
|
transitional cell carcinoma
|
IGFBP3*
|
Igfbp3
|
|
Alliance of Genome Resources
|